In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia.

Newer antipsychotics, such as clozapine, olanzapine, risperidone, quetiapine and ziprasidone, have a different receptor-binding profile, interacting with both D and 5-HT receptors; they less ...

Although antipsychotics were developed to treat schizophrenia, newer ones are sometimes used to treat depression that has not been relieved by antidepressants or other treatments. Depression is a ...

Second-generation antipsychotics, also known as atypical or newer antipsychotics, generally cause fewer side effects than first-generation (typical or older) antipsychotics. They are less likely ...

Newer antipsychotics, as alternatives to other sedative/hypnotic agents and older antipsychot ics, are used in post-stroke rehabilitation patients to manage delirium, agitation, insomnia ...